Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions.
Mikkel Lindskov SachsSofia Kälvemark SporrongMorten Colding-JørgensenSven FrokjaerPer HelboeKatarina JelicSusanne KaaePublished in: Pharmaceutical medicine (2017)
The study suggests that experience of AEs, related to either medicines or disease, constitutes an important factor of patient risk perception. We therefore propose that serious adverse experiences should be added to the traditional panel of socioeconomic factors that are accounted for when patients are invited to give input on regulatory decisions.